Wilson, D. Travis,Mooney, K. George,Oates, Peter J.
申请号：
AU2017254849
公开号：
AU2017254849A1
申请日:
2017.10.31
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017254849A120171116.pdf#####ABSTRACT The disclosure provides methods of preventing or treating ophthalmic diseases or conditions in a mammalian subject. The methods comprise administering an effective amount of an aromatic-cationic peptide to subjects in need thereof. More specifically, the disclosure provides a composition for preventing, treating, or ameliorating the symptoms of diabetic macular edema in a mammalian subject in need thereof, comprising: a therapeutically effective amount of a peptide D-Arg- 2'6'-Dmt-Lys-Phe-NH2 or a pharmaceutically acceptable salt thereof.
